2022
DOI: 10.18705/1607-419x-2022-28-1-87-95
|View full text |Cite
|
Sign up to set email alerts
|

Genetic comorbidity of hypertension and bronchial asthma

Abstract: Objective. To assess the association of single nucleotide polymorphisms of genes potentially involved in the comorbidity of bronchial asthma (BA) and essential hypertension (HTN) in patients with different time onset of the diseases.Design and methods. Genotyping of 92 SNPs was performed using MALDI-TOF mass spectrometry in patients with BA and HTN (n = 97) and healthy individuals (n = 153). The group of patients with comorbid pathology was divided into two subgroups depending on the time of onset of symptoms … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 29 publications
0
1
0
Order By: Relevance
“…The TLR4, CAT, ANG/RNASE4 genes can make the greatest contribution to the comorbidity of bronchial asthma and hypertension, indicating the importance of inflammation, neovascularization and oxidative stress for the pathogenesis of both diseases (Bragina et al, 2018). The development of bronchial asthma phenotypes in combination with cardiovascular/metabolic disorders is associated with certain genetic variants that affect gene expression, including CAT, TLR4, ELF5, ABTB2, UTP25, TRAF3IP3, NFKB1, LOC105377347, C1orf74, IRF6 and others, in the target organs of the studied disease profile (Bragina et al, 2022).…”
Section: Syntropies (Comorbidity)mentioning
confidence: 99%
“…The TLR4, CAT, ANG/RNASE4 genes can make the greatest contribution to the comorbidity of bronchial asthma and hypertension, indicating the importance of inflammation, neovascularization and oxidative stress for the pathogenesis of both diseases (Bragina et al, 2018). The development of bronchial asthma phenotypes in combination with cardiovascular/metabolic disorders is associated with certain genetic variants that affect gene expression, including CAT, TLR4, ELF5, ABTB2, UTP25, TRAF3IP3, NFKB1, LOC105377347, C1orf74, IRF6 and others, in the target organs of the studied disease profile (Bragina et al, 2022).…”
Section: Syntropies (Comorbidity)mentioning
confidence: 99%